Ligases Enzyme Market Report 2026

The ligases enzyme market size has grown rapidly in recent years. It will grow from $3.57 billion in 2025 to $3.99 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growth in molecular biology research, early adoption of ligase enzymes in cloning, expansion of academic research laboratories, increasing pharmaceutical R&D activities, rising use of enzymatic tools in diagnostics.

The ligases enzyme market size is expected to see rapid growth in the next few years. It will grow to $6.34 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for advanced genetic testing, expansion of next-generation sequencing applications, growing investments in biotechnology research, rising focus on personalized medicine, increasing adoption of ligase-based diagnostic techniques. Major trends in the forecast period include rising demand for enzymes in molecular cloning, increasing use of ligases in genetic research, growing adoption in diagnostic assays, expansion of ligase applications in drug discovery, rising preference for high-efficiency and specialty ligases.

The rising prevalence of cancer and genetic disorders is expected to drive the growth of the ligase enzyme market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, while genetic disorders encompass a wide range of medical conditions caused by abnormalities or mutations in an individual’s genetic material, particularly in their DNA. Ligase enzymes are crucial for DNA replication, repair, and recombination. In cancer, ligases can help repair damaged DNA, contributing to the uncontrolled growth of cells. Ligases can also be used to target and eliminate cells affected by genetic disorders. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia rose from 160,570 in 2022 to 164,694 in 2023, showing a significant increase over the year. This upward trend underscores the growing prevalence of cancer in the country. Additionally, 403 new cancer cases and 144 cancer-related deaths were reported per 100,000 people. Furthermore, in February 2023, according to Gene People UK, a UK-based registered charity, approximately 1 in 25 children in the UK are affected by a genetic condition, resulting in more than 2.4 million children and adults living with a genetic disorder, with 30,000 babies and children newly diagnosed each year. Therefore, the increasing prevalence of cancer and genetic disorders is fueling the growth of the ligase enzyme market.

The growth of the ligase enzyme market is expected to be driven by an increase in research and development activities in the coming years. Research and development (R&D) activities refer to the investigative efforts undertaken by a company or organization to enhance existing products and processes or to develop new products and processes. Ligase enzymes, also called DNA ligases, are vital for joining DNA molecules, making them essential tools in various R&D activities across multiple fields. For example, in February 2025, a report published by the National Science Foundation (NSF), a U.S.-based federal agency, stated that total research and experimental development (R&D) expenditures in the United States reached $892 billion in 2022, with projections rising to $940 billion in 2023. Consequently, the growth of the ligase enzyme market is being fueled by the expansion of research and development activities.

Major companies in the ligases enzyme market are advancing technologies such as nanopore technologies to increase the accuracy and efficiency of DNA sequencing and manipulation, ultimately enhancing applications in genomics, synthetic biology, and personalized medicine. Nanopore technologies use nanopores to detect and analyze molecules, such as DNA or proteins, by monitoring changes in ionic current as they pass through the pore. For example, in February 2023, Eurofins Genomics, a US-based biotechnology company, introduced the Express Oxford Nanopore Sequencing service. This service employs Oxford Nanopore technology, enabling the sequencing of long DNA fragments. This is especially useful for applications that require detailed genomic analysis, such as metagenomics and structural variant detection.

Major companies operating in the ligases enzyme market are New England Biolabs Inc., Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Creative Enzymes, ArcticZymes Technologies ASA, BLIRT S.A., Jena Bioscience, Enzo Life Sciences, BioVision Inc., Bioneer Corporation, Sino Biological Inc., Genetix Biotech Asia Pvt. Ltd., Omega Bio-tek Inc., Canvax Biotech, NZYGene, Vivantis Technologies, Toyobo Co. Ltd.

North America was the largest region in the ligases enzyme market in 2025. Asia-Pacific is expected to be the fastest-growing region in the ligases enzyme market report during the forecast period. The regions covered in the ligases enzyme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ligases enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the ligases enzyme market by increasing costs associated with imported raw materials, laboratory reagents, and enzyme production inputs. These effects are most evident across research-grade ligases and diagnostic applications, particularly in regions such as Asia-Pacific and Europe that depend on international biotechnology supply chains. Research laboratories and pharmaceutical companies face higher procurement costs and longer lead times due to tariff-related disruptions. On the positive side, tariffs have encouraged local enzyme manufacturing, supplier diversification, and regional production capabilities, strengthening long-term supply stability.

The ligases enzyme market research report is one of a series of new reports that provides ligases enzyme market statistics, including ligases enzyme industry global market size, regional shares, competitors with a ligases enzyme market share, detailed ligases enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the ligases enzyme industry. This ligases enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ligase enzymes are a class of proteins that facilitate the joining of two DNA strands. They are widely utilized in biotechnology and pharmaceuticals due to their crucial role in various cellular processes, including DNA replication and protein synthesis.

The main types of ligase products include E. coli DNA ligase, T4 DNA ligase, mammalian ligases, and thermostable ligases. E. coli DNA ligase is a specific type of DNA ligase enzyme obtained from Escherichia coli (E. coli) bacteria and can be sourced from microorganisms, animals, and plants. These enzymes are employed in a variety of applications, such as ligase chain reaction (LCR), ligase detection reaction (LDR), next-generation sequencing (NGS), repeat expansion detection (RED), rolling circle amplification (RCA), proximity ligation assay (PLA), molecular cloning, ligation-mediated PCR, and mutation detection. They are used by multiple end-users, including research laboratories and institutions, pharmaceutical and biopharmaceutical companies, and diagnostic laboratories.

The ligases enzyme market consists of sales of hi-t4 DNA ligase, splintR ligase, salt-t4 DNA ligase, t7 DNA ligase, quick ligation kits, Taq DNA ligase, and electroLigase. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.